$8.74
2.94% today
NYSE, Feb 05, 04:20 pm CET
ISIN
US29332G1022
Symbol
EHAB

Enhabit Stock price

$8.49
+0.72 9.27% 1M
-1.11 11.56% 6M
+0.68 8.71% YTD
-0.99 10.44% 1Y
-16.51 66.04% 3Y
-16.51 66.04% 5Y
-16.51 66.04% 10Y
NYSE, Closing price Tue, Feb 04 2025
+0.05 0.59%
ISIN
US29332G1022
Symbol
EHAB
Sector

Key metrics

Market capitalization $426.91m
Enterprise Value $992.31m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 18.90
EV/Sales (TTM) EV/Sales 0.96
P/S ratio (TTM) P/S ratio 0.41
P/B ratio (TTM) P/B ratio 0.75
Revenue growth (TTM) Revenue growth -2.22%
Revenue (TTM) Revenue $1.04b
EBIT (operating result TTM) EBIT $38.90m
Free Cash Flow (TTM) Free Cash Flow $52.50m
Cash position $47.40m
EPS (TTM) EPS $-2.32
P/E forward negative
P/S forward 0.41
EV/Sales forward 0.96
Short interest 4.00%
Show more

Is Enhabit a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Enhabit Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Enhabit forecast:

1x Buy
17%
5x Hold
83%

Analyst Opinions

6 Analysts have issued a Enhabit forecast:

Buy
17%
Hold
83%

Financial data from Enhabit

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,037 1,037
2% 2%
100%
- Direct Costs 563 563
1% 1%
54%
475 475
4% 4%
46%
- Selling and Administrative Expenses 405 405
1% 1%
39%
- Research and Development Expense - -
-
-
70 70
24% 24%
7%
- Depreciation and Amortization 31 31
1% 1%
3%
EBIT (Operating Income) EBIT 39 39
35% 35%
4%
Net Profit -117 -117
76% 76%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Enhabit directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Enhabit Stock News

Positive
Seeking Alpha
2 days ago
EHAB's investments in healthcare predictive analytics, expected to grow at 23%-24% CAGR, could significantly boost future net income growth. Restructuring, activism, and strategic reviews are potential catalysts for stock price appreciation, enhancing financial flexibility from 2025 to 2030. Despite recent negative net income, EHAB's consistent positive cash flow and undervaluation indicate sub...
Neutral
Business Wire
6 days ago
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, announced today that it is proud to be Certified™ by Great Place To Work®. This prestigious award is based entirely on the experiences of current employees working at Enhabit. This year, 83% of employees said it's a great place to work, which is 26 points higher than the average U.S. company. Great ...
Neutral
PRNewsWire
2 months ago
BIRMINGHAM, Ala., and DALLAS , Dec. 4, 2024 /PRNewswire/ -- On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit.
More Enhabit News

Company Profile

Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.

Head office United States
CEO Barbara Jacobsmeyer
Employees 10,800
Founded 2014
Website www.ehab.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today